High Unmet Needs in Therapeutics to Spur Growth in the Market for Nanotechnology in Drug Delivery, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Nanotechnology in Drug Delivery markets. The global market for Nanotechnology in Drug Delivery is projected to reach US$53.3 billion by 2018, driven by aging population, rising incidence of chronic diseases, high unmet medical needs, and advancements in nanomedicine and nano drug delivery.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Nanotechnology in Drug Delivery: A Global Strategic Business Report

San Jose, California (PRWEB) January 20, 2014

Follow us on LinkedIn – Pharmaceutical industry represents one of the early beneficiaries of advancements in nanotechnology. Nanotechnology holds the potential to dramatically alter the fields of drug delivery, drug discovery, in vivo imaging, in vitro diagnostics, tissue engineering and implants. Of all the areas of nanomedicine, drug delivery remains the most researched and commercialized areas for nanotechnology in medicine. Nanoscale delivery systems hold potential to reduce undesirable effects of medication while improving therapeutic efficacy. Advancements in this area is expected to result in re-investigation of molecules whose development was earlier shelved due to lower pharmaceutical activity but were known to be biologically active. Also, nanoscale delivery systems can help improve efficacy of certain drugs that are already on the market.

Business interests in the application of nanotechnology is fast rising, driven by rising intensity in research work in this area and growing competition within the general drug delivery technologies. The pharmaceutical industry is witnessing increasing demand for novel drug delivery technologies, as companies seek to minimize drug side effects, reduce quantity of costly active therapeutic agents, and endeavor to differentiate their products from competition as well as from commoditization. In this regard, nano-milled/nano-sized/nano-crystallized products and nanocarriers, such as liposomes, among other approaches are providing a new set of tools to address these issues. Nanomaterials provide novel functions and features that are not delivered by other drug delivery technologies. In addition to enhancing therapeutic efficacy and improving safety profile of existing drugs, nanotechnology has the potential to deliver an all important means of developing next generation drugs. The ability of dendrimers and micelles to act as imaging agents as well as therapeutic agents is a significant progress in this direction, assisting clinicians in imaging as well as treating tumors.

Nanotechnology-based drug delivery is being seen as a revolution in protein and gene therapy, for delivering biomolecules such as DNA and siRNA, enabling researchers to overcome several hurdles that are found in these therapies using conventional delivery systems. Given the harm caused by chemotherapeutic agents to healthy tissues alongside diseased cells, there is growing interest and efforts to deliver anti-cancer agents directly to tumors, using nanotechnology based delivery systems. In addition, efforts are underway to develop oral formulations of various therapeutic agents. While several drugs delivered orally breakdown in the stomach, nanotechnology-based drug delivery is being explored to ensure smooth passage of a medication through the stomach such that they enter the intestines and are absorbed by the intestinal walls and passed on to the blood stream.

As stated by the new market research report on Nanotechnology in Drug Delivery, the United States represents the largest market worldwide. Growth in the country is driven by various factors such as a strong pharmaceutical industry with robust expertise in related sciences, high focus on R&D, and narrowing drug pipelines of major pharmaceutical companies, among others. Asia-Pacific led by China is forecast to grow at the fastest CAGR of 70% over the analysis period. China is making rapid strides in the area of healthcare and pharmaceuticals. In recent years, the country has made healthcare improvement a domestic priority, with a special focus on introducing advanced medical technology. Nanocrystals dominate the market worldwide, supported by shorter development time and lower cost of production. Nanocarriers, such as liposomes, dendrimers and micelles are expected to witness strong growth in the coming years.

Major players covered in the report include Access Pharmaceuticals Inc., Alkermes PLC, Aquanova AG, Camurus AB, Capsulution Pharma AG, Celgene Inc., Flamel Technologies SA, Lena Nanoceutics Ltd., NanoBio® Corporation, and NanoCarrier Co. Ltd., among others.

The research report titled “Nanotechnology in Drug Delivery: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, drivers, challenges and strategic industry activities of major companies worldwide. The report provides market estimates and projections in US dollars for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific, Latin America and Rest of World. Product segments analyzed for the global market include Nanocrystals and Nanocarriers.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Nanotechnology_in_Drug_Delivery_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

Attachments